Showing results (261-270 of 1,371) with videos related to

Sort By:
Pageof 138
Drug Development Research|March 7, 2024
Hypoxia expedites the progression of papillary thyroid carcinoma by promoting the CPT1A-mediated fatty acid oxidative pathwayZhou Liang, Hongsheng He, Bing Zhang, et al.
Drug Development Research|July 3, 2024
Preliminary evaluation of antiproliferative and apoptotic activities of novel indolin-2-one derivativesGulseren Turhal, Busra Demirkan, Izel Nermin Baslilar, et al.
Drug Development Research|September 10, 2024
A thiourea-bridged 99mTc(CO)3-dipicolylamine-2-nitroimidazole complex for targeting tumor hypoxia: Utilizing metabolizable thiourea-bridge to improve pharmacokineticsSweety Mittal, Chandan Kumar, Laxmi Jha, et al.
Drug Development Research|September 9, 2024
A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignanciesChen Zhao, Yuan Zeng, Nannan Kang, et al.
Drug Development Research|September 10, 2024
The mechanism of action and chemical synthesis of FDA newly approved drug moleculesDan-Dan Shen, Yue-Lin Zhang, Xiang Li, et al.
Drug Development Research|September 30, 2024
Epigenetic mechanism of EZH2-mediated histone methylation modification in regulating ferroptosis of alveolar epithelial cells in sepsis-induced acute lung injuryYing Dai, Jiebin Chen, Qingning Duan
Drug Development Research|August 14, 2024
99mTc-labeled, tofacitinib citrate encapsulated chitosan microspheres loaded in situ gel formulations for intra-articular treatment of rheumatoid arthritisMerve Karpuz, Husniye Hande Aydin, Emre Ozgenc, et al.
Drug Development Research|August 21, 2024
Tirbanibulin (KX2-391) analog KX2-361 inhibits botulinum neurotoxin serotype A mediated SNAP-25 cleavage in pre- and post-intoxication models in cellsDilara Koc, Kubra Ibis, Peri Besarat, et al.
Drug Development Research|October 21, 2024
Design, synthesis, and evaluation of novel Indole-Based small molecules as sirtuin inhibitors with anticancer activitiesBusra Binarci, Ensar Korkut Kilic, Tunca Dogan, et al.
Drug Development Research|October 19, 2024
New S-substituted-3-phenyltetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one scaffold with promising anticancer activity profile through the regulation and inhibition of mutated B-RAF signaling pathwaySafaa E Seif, Wagnat W Wardakhan, Rasha A Hassan, et al.
Pageof 138